Evaluation of the possible association of body mass index and four metabolic gene polymorphisms with longevity in an Italian cohort: a role for APOE, eNOS and FTO gene polymorphisms by Santovito, Alfredo et al.
For Peer Review Only
Evaluation of the possible association of Body Mass Index 
and four metabolic gene polymorphisms with longevity in 
an Italian cohort: a role for APOE, eNOS, and FTO gene 
polymorphisms.
Journal: Annals of Human Biology
Manuscript ID TAHB-2019-0092
Manuscript Type: Research Paper
Keywords: aging, angiotensin-converting enzyme, apolipoprotein, endothelial nitric oxide, fat mass and obesity-associated gene
 
URL: http://mc.manuscriptcentral.com/tahb E-mail: annals@lists.lboro.ac.uk
Annals of Human Biology
For Peer Review Only
ABSTRACT
Background: longevity is considered the result of interactions between environmental and genetic 
factors.
Aim: we investigated the possible association of body mass index and the frequencies of APOE, 
ACE, eNOS, and FTO gene polymorphisms with longevity. 
Subjects and Method: 1,100 healthy volunteers aged 10-100 were recruited. We genotyped 
subjects for APOE, ACE, eNOS, and FTO gene polymorphisms.  Data about height and weight were 
also collected. The sample was split in four age groups: 1-24, 25-49, 50-85 and 86-100. 
Results: significant differences were found in BMI values between age groups, with exception of 1-
24 with respect to 86-100. A significant decrease of the APO E4, eNOS 393 and FTO A and allele 
frequencies was observed in the 86-100 age group with respect to younger groups. For ACE gene, 
no significant differences were found in the allele frequencies between groups. A similar trend was 
also observed subdividing the sample in two main age groups: 1-85 and 86-100. 
Conclusion: this study provides evidences for a role of APOE, eNOS, and FTO gene 
polymorphisms in longevity. It has been estimated that the number of centenarians worldwide will 
double each decade until 2100, making population data about gene polymorphisms relevant for 
further studies about longevity.
Keywords: aging, angiotensin-converting enzyme; apolipoprotein; endothelial nitric oxide; fat 
mass and obesity-associated gene
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1. INTRODUCTION
Longevity is generally considered as the result of interactions between environmental 
and genetic factors. Among the environmental factors, life-style and the nutritional status seem 
to play an important role in the incidence of many age-related diseases. For example, high 
levels of adiposity, typical of individuals with a body mass index (BMI) more than 30 kg/m2, 
were linked to abnormal glucose metabolism and increased incidence of cardiovascular diseases 
(CVDs), cancer and neurodegenerative diseases, with consequently higher mortality rate 
(Srikanthan and Karlamangla, 2014). 
Moreover, since CVDs are the main causes of death worldwide (WHO, 2011), polymorphisms 
in genes involved in these types of diseases, as well as those involved in vascular dysfunction 
and obesity, represent excellent candidates for longevity. 
Apolipoprotein E (APOE) gene is one of the most consistently associated with human 
longevity (Fuku et al., 2017). The glycoprotein encoded by this gene plays a fundamental role in the 
lipid metabolism, mediating lipoprotein binding to the LDL and lipoprotein remnant receptors. 
Defects in this protein could diminish its ability to bind to the receptors, which then leads to an 
elevated blood cholesterol level and, consequently, to increased risk of atherosclerosis and CVDs 
(Marrzoq et al., 2011). APOE gene is polymorphic, with three common alleles E2, E3, and E4, that 
give rise to six different genotypes E2/2, E2/3, E2/4, E3/3, E4/3, and E4/4 (Marrzoq et al., 2011). 
The E4 allele is the most common APOE allele in all human populations and it is associated with 
higher total cholesterol levels and increased risk of metabolic and neurodegenerative diseases, 
whereas E2 and E3 alleles were associated with lower cholesterol levels and with a protective role 
against Alzheimer’s disease (de-Almada et al., 2012; Marrzoq et al., 2011).
Another gene associated with CVDs is the ACE gene, that encodes an enzyme that catalyzes 
the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. In human populations 
this gene is polymorphic due to the presence (insertion, allele I) or absence (deletion, allele D) of an 
Alu sequence of 287-bp in intron 16. In some studies, individuals with Alzheimer’s disease have 
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been reported to show an increased frequency of I allele, while homozygosity of the ACE D allele 
has been associated with an increased risk for CVDs and hypertension (Garatachea et al., 2013). 
Endothelial nitric oxide, synthesized by nitric oxide synthases gene (eNOS), plays a crucial 
role in the regulation of vascular tone. It diffuses from the endothelium to vascular smooth muscle 
cells, causing vascular relaxation and inhibiting the cellular proliferation. During aging, there is a 
progressive reduction of NO production, whereas the oxidative stress increases as a consequence of 
the absence of a compensatory enhancement of antioxidant defences. The result of this reduction of 
the available NO, is the alteration of the vascular homeostasis with possible increased risk for 
hypertension, atherosclerosis, thrombosis, and stroke (Puca et al., 2012). Several polymorphisms 
were reported in the promoter region, exons and introns of this gene. An important one is 
represented by a 27-base pair core consensus VNTR (variable number of tandem repeats) 
polymorphism in the intron 4: the common wild-type ‘b-allele’ (eNOS4b allele) has five tandem 27-
bp repeats, while the rare ‘a-allele’ (eNOS4a allele) only four repeats. In particular, the eNOS 4a 
allele was found to be an independent risk factor of myocardial infarction, whereas the eNOS 4a/4a 
homozygote was identified as a smoking dependent risk factor of myocardial infarction (Park et al., 
2004). 
Finally, fat mass and obesity-associated (FTO) gene is another CVDs risk candidate gene, 
also associated to obesity and BMI. The common single-nucleotide polymorphism, rs9939609, 
located in the first intron of the FTO gene is one of the most important variants that have been 
examined by many genome wide association studies, with the allele A strongly associated with 
obesity phenotype, increased BMI values, CAD and metabolic syndrome (Qi et al., 2014; Reitz et 
al., 2012). 
The main objectives of this study were to investigate the possible association of BMI, of 
some metabolic (APOE, ACE, eNOS, and FTO) gene polymorphisms and longevity in a northern 
Italy cohort. The hypothesis is that some anthropometric parameters, such as the BMI, and some 
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genetic variants could be differentially represented in long-lived individuals with respect younger 
subjects. 
2. MATERIALS AND METHODS
2.1 - Study population
The study was conducted on a cohort of 1,100 healthy Italian subjects (aged 10-100 years; 546 
males and 554 females) of Caucasian origin from Northern Italy. All the subjects were randomly 
chosen healthy volunteers, received detailed information about the study, were anonymously 
identified by a numeric code and gave their informed consent prior the analyses. Inclusion criteria 
for the control group were being a man or woman with no history of stroke, cardiovascular disease, 
diabetes, neurodegenerative and cancer diseases. The research protocol was approved by the local 
ethics committee and was performed in accordance with the ethical standards laid down in the 2013 
Declaration of Helsinki. 
In Italy, in 2017, the average life expectancy at birth was 80.6 years for men and 84.9 years for 
women (ISTAT, 2017a). Moreover, the fertility rate for women belonging to the 20-49 age group 
was about 90%, with an average age of mothers and fathers at the birth of their first child of 31.8 
and 35.3 years, respectively (ISTAT, 2017a,b). For these reasons, in order to evaluate the possible 
association of some alleles with longevity, we decided to divide our sample into 4 age groups: 1-24, 
that include subjects in pre-reproductive phase; 25-49, that included subjects in reproductive phase; 
50-85, representing the group of subjects in post- reproductive phase; and 86-100 that represent the 
group with long-lived individuals. 
2.2 - DNA extraction and Genotyping
Peripheral blood samples (5-10 ml obtained by venipuncture) were collected in heparinized 
vacutainers and stored at -20°C. DNA extraction was conducted using a Chelex solution, according 
to Santovito et al. (2017). Gene polymorphisms were determined by PCR and RFLP 
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methodologies, using primers and melting temperature as described in Table 1. PCR reactions were 
performed in a 25 μL volume containing about 10 ng DNA (template), with a final concentration of 
1X Reaction Buffer, 1.5 mM of MgCl2, 5% of DMSO, 250 µM of dNTPs, 0.5 μM of each primer, 
and 1 U/sample of Taq DNA polymerase (Fischer, U.S.). Cycles were set as follows: 35 cycles, 1 
min at 95°C, 1 min at 56-65°C depending on the primer sequence (Table 1), 1 min at 72°C, and a 
final extension step 10 min at 72 °C. Amplification products were detected by ethidium bromide 
staining after 4% metaphor agarose gel electrophoresis. The expected PCR and/or RFLP product 
size for each gene polymorphism analysed were showed in Table 1.
To verify the genotyping results, 10% of the total sample (n = 110) were also analysed by another 
investigator. The two analyses showed identical results.
2.2 - Statistical Analysis
SPSS software statistical package program version 25.0 for Windows (SPSS, Inc., Chicago, USA) 
was used for all statistical analyses. Pearson’s χ2 test was conducted for Hardy-Weinberg 
equilibrium (HWE) and to compare allele or genotype frequencies between different age groups, 
whereas the ANOVA test was used in order to evaluate possible differences in BMI values between 
age groups. Finally, multiple regression analysis was also used to evaluate the influence of age on 
BMI. All P-values were two tailed and the level of statistical significance was set at P<0.05 for all 
tests. 
3. RESULTS
In Table 2 the general characteristics of the studied population are reported. A total of 1,100 
subjects, 546 males (mean age ± SD: 54.423±21.128, age range: 10-98) and 554 females (mean age 
± SD: 57.314±24.038, age range: 10-100) were recruited.
No significant differences were found between males and females in terms of mean age and BMI 
values. Vice versa, significant differences were found in terms of BMI values between age groups, 
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with exception of 1-24 with respect to 86-100 age groups. This result was confirmed by both the 
ANOVA analysis (P <0.001) and regression analysis (P = 0.021) that showed a significant 
correlation between age and BMI.  
In Table 3 the allele and genotype frequencies for all studied genes are reported. All genotype 
frequencies resulted in accordance with the Hardy-Weinberg law.
Analysing the frequencies of the studied gene polymorphisms (Table 4), we observed a significant 
decrease of the APO E4 allele frequency and a significant increase of the APO E2 allele frequency 
in the 86-100 age group with respect to 1-24 (P = 0.005) and 25-49 (P = 0.007) age groups. 
Similarly, the older age group showed a significant (P<0.001) reduction of eNOs 393 and FTO A 
alleles with respect to 1-24 and 25-49 age groups. Finally, for ACE, no significant differences in the 
allele frequencies between age groups were found. 
A similar trend was also observed subdividing the sample in 1-85 and 86-100 age groups (Table 4). 
Also in this case, we observed a significant (P<0.001) decrease of the APO E4 and a significant 
increase of the APO E2 allele frequencies in the 86-100 age group with respect to 1-85 age group (P 
= 0.012). Moreover, the older age group showed a significant (P<0.001) reduction of eNOS 393 and 
FTO A alleles with respect to 1-85 age group, whereas for the other three studied gene 
polymorphisms no significant differences in the allele frequencies were found between age groups. 
4. DISCUSSION
In humans, exceptional longevity is a complex trait. Studies focused on the determination of genetic 
features of long-lived individuals, represent one of the main approaches to define the key 
components of this longevity. 
Among the anthropometric parameters associated with longevity, BMI seems to play an important 
role (Frayling et al., 2007). We reported a significant increase of BMI with age, probably ascribed 
to a significant increase of this parameter in the 25-49 and 50-84 age groups, as indicated by the 
non-parametric analysis (Table 2). The lack of significant differences in terms of BMI values 
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between younger and older groups could be explained by the fact that, since in old age there is a 
change in the balance between fat and muscle mass, BMI becomes less useful in assessing the 
metabolic health of older adults (Srikanthan and Karlamangla, 2014). 
Long-living individuals are characterized by a low incidence of cardiovascular and 
neurodegenerative diseases (Puca et al., 2012). From genetic point of view, this phenomenon may 
be due to the presence or absence of specific gene polymorphisms, that confer to the carriers a 
better ability to counteract cell deterioration during aging (Nijiati et al., 2013). One of the most 
frequent candidate genes that have been studied for its possible association with longevity were 
APOE gene. In particular, APOE2 was found to be associated with lower levels of total and LDL 
cholesterol and with higher levels of HDL cholesterol, while APOE4 has opposite effects. As 
consequence, the APOE4 allele has b en linked to atherosclerosis and coronary heart disease and 
individuals with E4/E4 genotype are at a higher risk of cardiovascular and Alzheimer’s diseases 
(Marrzoq et al., 2011). For these reasons, long-lived individuals would be expected to have higher 
frequencies of E2 allele and lower frequencies of E4 allele with respect to younger age groups. 
Results of our work seem to confirm these hypotheses, since, in the 86-100 age group, we found a 
significant decrease of the APOE4 allele frequency and a significant increase of the APOE2 allele 
frequency with respect to younger group. 
Differently to APOE, data about the association of ACE I/D gene polymorphism and 
longevity are controversy, and results from the published literature provides evidence for a modest 
positive association between the ACE D-allele and D/D genotype and exceptional human longevity 
(for a review see Garatachea et al., 2013). For instance, a published meta-analysis showed that, 
compared with I/I genotype, the D/D genotype is associated with an increase risk for ischaemic 
stroke and the D allele with a 14% increased risk of type II diabetes, with respect to the I variant 
(Zhou et al., 2010). Paradoxically, the same (D) allele which predisposes to CAD has been reported 
to be more frequent in some cohorts of European centenarians, including from France (Faure-
Delanef et al., 1998), United Kingdom (Galinsky et al., 1997), Italy (Seripa et al., 2006), as well as 
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in nonagenarians and centenarians from the Uighur population in China (Rahmutula et al., 2002), 
suggesting a pleiotropic effect of this gene. However, the association between the D allele and 
increased longevity has not been replicated in other studies on centenarians from Denmark 
(Bladbjerg et al., 1999), France (Blanche et al., 2001), Italy (Paolisso et al., 2001), China (Yang et 
al., 2009) and Spain (Fiuza-Luces, 2011). 
Also our data, do not give support for a significant role of the ACE I/D polymorphism on human 
longevity. These contradictory results could be attributed to different factors, including the ethnic 
background and the sample size of the cohorts. Indeed, the frequency of the I allele decreases from 
Northern to Southern Europe, as well as Caucasian and African populations present similar 
frequencies and differ from those observed in Asian, Amerindian and Polynesian populations 
(Fiuza-Luces, 2011). Moreover, the sample size limitation is a relative common problem in studies 
with centenarians owing to the difficulty of gathering cases, being living 100 or more years still a 
rare phenotype.
FTO gene is another longevity-related gene whose common variants were found to be 
associated to obesity and diabetes (Speakman JR, et al., 2008). In particular, the polymorphism 
rs9939609, is characterized by the presence of the two common alleles A and T, where the 
frequency of the minor allele (A) shows a moderate variation in the different European populations, 
ranging from 0.32 to 0.47 (Osier et al., 2002). In humans, the presence of a copy of the allele A was 
found to be associated with an average weight increase of 1.2 kg, and the presence of two A alleles 
with an increase of about 3 kg compared to the TT genotype  (Frayling et al., 2007). The increase in 
adipose tissue in the A allele carriers was found also associated with a atherogenic lipid profile and 
with higher incidence of myocardial infarction (Doney et al., 2009). Also in this case we can 
hypothesize a pleiotropic effect of FTO gene that manifests itself with an increased fitness for the 
allele A carriers in reproductive age and with a lower fitness for the same carriers in old age. Our 
data confirm this hypothesis, with a frequency of A allele significantly reduced in the older group 
with respect to the younger. 
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Finally, we found a significant reduction of the eNOS 393 allele in the older group with respect to 
1-24 and 25-49 age groups. This result seems to confirm the hypotheses of a possible correlation 
between this gene polymorphism and natural longevity, as postulated by different authors (Nijiati et 
al., 2013; Puca et al., 2012; Park et al., 2004). It is known that nitric oxide plays a protective role in 
various important events during atherogenesis, inducing smooth muscle relaxation, inhibition of 
platelet aggregation, leukocyte adhesion to endothelial cells and preservation of endothelial 
progenitor cell function (for a review see Puca et al., 2012). However, during aging, there is a 
progressive misbalance between NO production, which becomes increasingly reduced, and 
oxidative stress, which increases without a compensatory enhancement of antioxidant defences. As 
a result, vasodilator function of aged vessels could be compromised, with consequent increase of 
vascular resistance and impaired perfusion (Forstermann, 2010). In this scenario, eNOS may be 
critically involved in longevity by increasing the deteriorative effects of aging. In particular, the 
eNOS 4a allele and eNOS 4a/4a genotype were found to be independent risk factors of myocardial 
infarction (Park et al., 2004), and their frequencies are expected to be lower in long-lived subjects, 
as actually observed in our sample.
5. CONCLUSIONS
Our results showed an age-related relationship of APOE, FTO and eNOS gene polymorphisms in a 
cohort of healthy Italian subjects. Despite the limitation of studies like this, due to the difficulty of 
finding a substantial number of centenarians and, in general, of long-lived people, it is our opinion 
that the present work could be relevant for further studies about longevity among Italian and 
European populations. Finally, it has been estimated that the number of centenarians worldwide 
will double each decade until 2100 (Nijiati et al., 2013), making these studies increasingly 
important in the future.
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Table 1 - Primers and annealing temperatures for gene polymorphisms analysed in the present study
Gene Sequence T (°C) Methodology PCR product (bp) Reference
ACE 5’ - CTGGAGACCACTCCCATCCTTTCT- 3’5’ - GATGTGGCCATCACATTCGTCAGAT – 3’ 58 PCR
190 (D-allele)
490 (I-allele)
Álvarez et 
al., 1998
APOE 5’- TCCAAGGAGCTGCAGGCGGCGCA - 3’5’- GCCCCGGCCTGGTACACTGCCA - 3’ 65
RFLP
(AflIII-HaeII)
E2 = 168 bp
E3 = 145 bp
E4 = 195 bp
Zivelin et 
al., 1997
eNOs 5′ - AGGCCCTATGGTAGTGCCTTT - 3′5′ - TCTCTTAGTGCTGTGGTCAC - 3′ 56 PCR
420 (five 27-bp repeats)
393 (four 27-bp repeats)
Tsukada et 
al., 1998
FTO 5’- AACTGGCTCTTGAATGAAATAGGATTCAGA -3’5’- AGAGTAACAGAGACTATCCAAGTGCAGTAC -3’ 63
RFLP
(ScaI)
TT = 182
AA = 154+28
TA = 182+154+28
Abdelmajed 
et al., 2017
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Table 2 - General characteristics of the studied population.
Subjects N (%) Age, Mean ± S.D.(range) BMI, Mean ± S.D.
Total 1100 55.879±22.676 26.299±4.262
Sex
Males 546 (49.64) 54.423±21.128 
(10-98)
26.316±4.114
Females 554 (50.36) 57.314±24.038 
(10-100)
26.281±4.406
Age groups
1-24 117 (10.64) 19.120±4.369 24.730±4.307 a,b
25-49 352 (32.00) 37.594±6.985 26.073±3.797 c,d
50-85 521 (47.36) 69.317±9.613 27.163±4.359 e
86-100 110 (10.00) 89.845±0.279 24.598±4.126
S.D. = Standard Deviation
aP = 0.015 with respect to 25-49 age group 
b, c P <0.001 with respect to 50-85 age group
dP =0.006 with respect to 86-100 age group
eP <0.001 with respect to 86-100 age group
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Table 3 – Allele and Genotype Frequencies of seven metabolic gene polymorphisms in an Italian sample (n = 1,100)
Gene polymorphisms Allele N Frequency Genotype N Frequency HWEP-value
ACE
APOE 
FTO
eNOs
D
I
E3
E4
E2
T
A
420
393
1698
502
1855
278
67
1417
783
1842
358
0.772
0.228
0.843
0.126
0.031
0.644
0.356
0.837
0.163
DD
ID
II
E3E3
E3E4
E2E3
E4E4
E2E4
TT
TA
AA
420/420
429/393
393/393
643
412
45
784
227
60
22
7
470
477
153
721
263
35
0.585
0.374
0.041
0.713
0.206
0.055
0.020
0.006
0.427
0.434
0.139
0.708
0.258
0.034
0.110
0.237
0.199
0.203
HWE = Hardy-Weinberg Equilibrium.  
* The HWE was not calculated because the used genotyping procedure does not consent to discriminate the 
heterozygotes from homozygotes
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Table 4 - Frequencies of the studied metabolic gene polymorphisms among different age groups
* P = 0.005, with respect to 86-100 age group; ** P = 0.007, with respect to 86-100 age group
*** P < 0.001, with respect to 86-100 age group; **** P = 0.012, with respect to 1-85 age group
AGE GROUPS
GENE 1-24
N = 117
25-49
N = 352
50-85
N = 521
86-100
N = 110 
1-85
N = 990
86-100
N = 110 
ACE
DD
ID
II
Allele D
Allele I
APOE
64
49
4
177 (0.756)
57 (0.244)
205
129
18
529 (0.766)
165 (0.234)
310
192
19
812 (0.778)
230 (0.222)
64
42
4
170 (0.773)
38 (0.227)
579
370
41
1528 (0.772)
452 (0.228)
64
42
4
170 (0.773)
38 (0.227)
E3E3 77 244 377 86 698 86
E3E4 32 83 99 13 214 13
E4E4 2 7 12 1 21 1
E2E3 4 16 30 10 50 10
E2E4 2 2 3 0 7 0
Allele E2
Allele E3
6 (0.026)
190 (0.812)
18 (0.026)
587 (0.834)
33 (0.032)
883 (0.847)
10  (0.046)
195 (0.886)
57 (0.029) 
1660 (0.838)
10  (0.046)
195 (0.886)
Allele E4 38 (0.162) * 99 (0.141) ** 126 (0.121) 15  (0.068) 263 (0.133) 15 (0.068)****
eNOs
420/420 72 240 371 96 683 96
393/420 40 109 123 12 272 12
393/393 5 3 27 2 35 2
Allele 420 184 (0.786) 589 (0.837) 865 (0.830) 204 (0.927) 1638 (0.827) 204 (0.927)
Allele 393 50 (0.214) *** 115 (0.163) *** 177 (0.170) 16 (0.073) 342 (0.173)* 16 (0.073)
FTO
TT 47 158 199 66 404 66
TA 51 142 245 39 438 39
AA 19 52 77 5 148 5
Allele T 145 (0.620) 458 (0.651) 643 (0.617) 171 (0.777) 1246 (0.629) 171 (0.777)
Allele A 89 (0.380)*** 246 (0.349)*** 399 (0.383) 49 (0.223) 734 (0.371)*** 49 (0.223)
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